Francesco D'Amore

6PUBLICATIONS
107CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 13, 2025
Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case Series.

Signe Hedebo, Martin B Pedersen, Lise M Lindahl

|Oct 03, 2024
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.

Anja Fischer, Thomas K Albert, Natalia Moreno

|Oct 26, 2023
Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial.

Stefano Luminari, Alexander Fossa, Judith Trotman

|Aug 24, 2022
Genomic profiling for clinical decision making in lymphoid neoplasms.

Laurence de Leval, Ash A Alizadeh, P Leif Bergsagel

|May 31, 2022
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.

Tyler A Herek, Alyssa Bouska, Waseem Lone

Pageof 1

Frequent Collaborators

2 joint publications

Andrew L Feldman

2 joint publications

Julie Vose

2 joint publications

Stefano Pileri

2 joint publications

Judith Trotman